| Prevalence of nuclear and mitochondrial DNA mutations related to adult mitochondrial disease GS Gorman, AM Schaefer, Y Ng, N Gomez, EL Blakely, CL Alston, ... Annals of neurology 77 (5), 753-759, 2015 | 531 | 2015 |
| Phenotypic spectrum associated with mutations of the mitochondrial polymerase γ gene R Horvath, G Hudson, G Ferrari, N Fütterer, S Ahola, E Lamantea, ... Brain 129 (7), 1674-1684, 2006 | 396 | 2006 |
| Clinical expression of Leber hereditary optic neuropathy is affected by the mitochondrial DNA–haplogroup background G Hudson, V Carelli, L Spruijt, M Gerards, C Mowbray, A Achilli, A Pyle, ... The American Journal of Human Genetics 81 (2), 228-233, 2007 | 345 | 2007 |
| Multi-system neurological disease is common in patients with OPA1 mutations P Yu-Wai-Man, PG Griffiths, GS Gorman, CM Lourenco, AF Wright, ... Brain 133 (3), 771-786, 2010 | 330 | 2010 |
| Universal heteroplasmy of human mitochondrial DNA BAI Payne, IJ Wilson, P Yu-Wai-Man, J Coxhead, D Deehan, R Horvath, ... Human molecular genetics 22 (2), 384-390, 2013 | 315 | 2013 |
| The myopathic form of coenzyme Q10 deficiency is caused by mutations in the electron-transferring-flavoprotein dehydrogenase (ETFDH) gene K Gempel, H Topaloglu, B Talim, P Schneiderat, BGH Schoser, VH Hans, ... Brain 130 (8), 2037-2044, 2007 | 292 | 2007 |
| Use of whole-exome sequencing to determine the genetic basis of multiple mitochondrial respiratory chain complex deficiencies RW Taylor, A Pyle, H Griffin, EL Blakely, J Duff, L He, T Smertenko, ... Jama 312 (1), 68-77, 2014 | 277 | 2014 |
| Late onset Pompe disease: clinical and neurophysiological spectrum of 38 patients including long-term follow-up in 18 patients W Müller-Felber, R Horvath, K Gempel, T Podskarbi, Y Shin, D Pongratz, ... Neuromuscular Disorders 17 (9-10), 698-706, 2007 | 259 | 2007 |
| Mutation in TACO1, encoding a translational activator of COX I, results in cytochrome c oxidase deficiency and late-onset Leigh syndrome W Weraarpachai, H Antonicka, F Sasarman, J Seeger, B Schrank, ... Nature genetics 41 (7), 833, 2009 | 254 | 2009 |
| SDHAF1, encoding a LYR complex-II specific assembly factor, is mutated in SDH-defective infantile leukoencephalopathy D Ghezzi, P Goffrini, G Uziel, R Horvath, T Klopstock, H Lochmüller, ... Nature genetics 41 (6), 654-656, 2009 | 249 | 2009 |
| Mutations in COX10 result in a defect in mitochondrial heme A biosynthesis and account for multiple, early-onset clinical phenotypes associated with … H Antonicka, SC Leary, GH Guercin, JN Agar, R Horvath, NG Kennaway, ... Human molecular genetics 12 (20), 2693-2702, 2003 | 243 | 2003 |
| Risk of developing a mitochondrial DNA deletion disorder PF Chinnery, S DiMauro, S Shanske, EA Schon, M Zeviani, C Mariotti, ... The Lancet 364 (9434), 592-596, 2004 | 229 | 2004 |
| The human cytochrome c oxidase assembly factors SCO1 and SCO2 have regulatory roles in the maintenance of cellular copper homeostasis SC Leary, PA Cobine, BA Kaufman, GH Guercin, A Mattman, J Palaty, ... Cell metabolism 5 (1), 9-20, 2007 | 215 | 2007 |
| Mitochondrial aging is accelerated by anti-retroviral therapy through the clonal expansion of mtDNA mutations BAI Payne, IJ Wilson, CA Hateley, R Horvath, M Santibanez-Koref, ... Nature genetics 43 (8), 806-810, 2011 | 211 | 2011 |
| Polymerase γ Gene POLG determines the risk of sodium valproate‐induced liver toxicity JD Stewart, R Horvath, E Baruffini, I Ferrero, S Bulst, PB Watkins, ... Hepatology 52 (5), 1791-1796, 2010 | 192 | 2010 |
| Identification of an X-chromosomal locus and haplotype modulating the phenotype of a mitochondrial DNA disorder G Hudson, S Keers, PYW Man, P Griffiths, K Huoponen, ML Savontaus, ... The American Journal of Human Genetics 77 (6), 1086-1091, 2005 | 182 | 2005 |
| Extending the KCNQ2 encephalopathy spectrum: clinical and neuroimaging findings in 17 patients S Weckhuysen, V Ivanovic, R Hendrickx, R Van Coster, H Hjalgrim, ... Neurology 81 (19), 1697-1703, 2013 | 168 | 2013 |
| Mitochondria: impaired mitochondrial translation in human disease V Boczonadi, R Horvath The international journal of biochemistry & cell biology 48, 77-84, 2014 | 163 | 2014 |
| The prevalence and natural history of dominant optic atrophy due to OPA1 mutations P Yu-Wai-Man, PG Griffiths, A Burke, PW Sellar, MP Clarke, L Gnanaraj, ... Ophthalmology 117 (8), 1538-1546. e1, 2010 | 153 | 2010 |
| New treatments for mitochondrial disease—no time to drop our standards G Pfeffer, R Horvath, T Klopstock, VK Mootha, A Suomalainen, S Koene, ... Nature Reviews Neurology 9 (8), 474-481, 2013 | 152 | 2013 |
